🇺🇸 FDA
Company

PDS

PDS Biotechnology Corp

PDSB biotech USA

Quick answer

PDS is a biotech company (PDSB) headquartered in PRINCETON, NJ, USA with 3 tracked pipeline programs.

Pipeline (3)

project

Combination Treatment of PDS0101 and Pembrolizumab

Recurrent Head and Neck Cancer

Phase 3 · other · active

1 trials project

Pembrolizumab (KEYTRUDA®) and PDS0101

Metastatic Head and Neck Cancer

Phase 2 · other · completed

1 trials project

R-enantiomer of 1,2-dioleoyl-3-trimethylammonium-propane chloride + Peptides from HPV-16 E6 and E7

High-risk HPV Infection and Biopsy-proven CIN1

Phase 1 · mab · completed

1 trials

Patents (8)

patent

US 11911359

Stimulation of an immune response by cationic lipids

Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11911465

Vaccine compositions and methods of use

Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11904015

Vaccine compositions and methods of use

Expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11801257

Stimulation of an immune response by enantiomers of cationic lipids

Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11638753

Lipids as synthetic vectors to enhance antigen processing and presentation ex-vi

Expires Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11612652

Lipids as synthetic vectors to enhance antigen processing and presentation ex-vi

Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11401306

HPV16 non HLA-restricted t-cell vaccines, compositions and methods of use thereo

Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10702541

Stimulation of an immune response by enantiomers of cationic lipids

Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)